Development of a NanoBioAnalytical platform for "on-chip" qualification and quantification of platelet-derived

Sameh Obeid1, Adam Ceroi2, Guillaume Mourey2

  • 1FEMTO-ST Institute, UBFC, CNRS, ENSMM, UTBM, 15B Avenue des Montboucons, 25030 Besançon, France.

Biosensors & Bioelectronics
|September 7, 2016
PubMed

Insights

This study introduces a novel NanoBioAnalytical platform combining surface plasmon resonance (SPR) and atomic force microscopy (AFM) for simultaneous detection, characterization, and quantification of blood microparticles (MPs). The method offers sensitive, label-free analysis of MPs, crucial for biomarker discovery.

Area of Science:

  • Biotechnology
  • Nanotechnology
  • Analytical Chemistry

Background:

  • Blood microparticles (MPs) are cell-derived vesicles implicated in biological processes and disease.
  • Current methods struggle with simultaneous quantification and qualification of total MPs.
  • A need exists for advanced techniques to analyze MPs for diagnostic potential.

Purpose of the Study:

  • To develop and validate a novel NanoBioAnalytical platform for simultaneous detection, characterization, and quantification of MPs.
  • To assess the capability of Surface Plasmon Resonance (SPR) coupled with Atomic Force Microscopy (AFM) for MP analysis.
  • To characterize platelet-derived microparticles (PMPs) using this combined SPR-AFM approach.

Main Methods:

  • Utilized a Surface Plasmon Resonance (SPR) biosensor for MP capture via specific ligands.
  • Integrated Atomic Force Microscopy (AFM) for high-resolution imaging and metrological analysis of captured MPs.
  • Employed Virus-Like Particles (VLPs) and synthetic beads as calibration standards for quantification.

Main Results:

  • The SPR-AFM platform enabled sensitive, reproducible, and label-free characterization and quantification of MPs.
  • AFM analysis revealed that over 95% of captured PMPs were smaller than 300nm.
  • The method demonstrated a wide quantification range (≈10^7 to 10^12 particles/mL) with a low limit of detection.

Conclusions:

  • The combined SPR-AFM NanoBioAnalytical platform is a powerful tool for comprehensive MP analysis.
  • This approach facilitates sensitive and accurate quantification and qualification of MPs across a broad concentration spectrum.
  • The platform holds significant potential for advancing MP-based diagnostics and understanding their biological roles.

Related Concept Videos